What Experts Really Think About Diet Soda
Growing up, Olivia Dreizen Howell, 39, “lived on” diet soda. So did her family. At a family reunion in 1996, everyone sported T-shirts with their shared surname in Diet Coke-can font. “We drank Diet Coke, Diet ginger ale, and Diet Sprite like water—there was no difference in our household,” she says.
Like many, Howell believed that sugar-free soda was a benign choice. But the latest research casts doubt on that assumption, linking diet drinks to mood disorders, fatty liver development, autoimmune diseases, and cancer, to name a few.
[time-brightcove not-tgx=”true”]
Bef...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Perri Ormont Blumberg Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news
Bone health appears normal in transgender youth on hormone therapy
Bone mineral density (BMD) is only slightly below the normal average among transgender youth undergoing gender-affirming hormone therapy, according to a study by researchers at the University of Colorado in Aurora.
A team of pediatricians analyzed results from dual energy x-ray absorptiometry (DEXA) scans in a group of transgender youth who participated in a trial at Children's Hospital Colorado between 2016 and 2018 to evaluate insulin sensitivity and body composition. The finding may be reassuring for youths undergoing gender-affirming care, noted lead author and medical student Micaela Roy.
“Total body BMD Z-scores ...
Source: AuntMinnie.com Headlines - April 5, 2024 Category: Radiology Authors: Will Morton Tags: Digital X-Ray Source Type: news
How Abdominal Fibrogenesis Affects Adolescents With Obesity How Abdominal Fibrogenesis Affects Adolescents With Obesity
Abdominal fibrogenesis increased significantly, while the adipose tissue expandability remained unaffected in insulin-resistant adolescents with obesity.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 3, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
Basal Insulin Non-Adherence Is Common in Type 2 Diabetes Basal Insulin Non-Adherence Is Common in Type 2 Diabetes
About 44% were non-adherent within 12 months.Medscape UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 2, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
World-first artificial pancreas roll-out will see up to 150,000 diabetics get the life-changing gadgets on the NHS
The device - known as a hybrid closed-loop system - uses a hi-tech algorithm to determine the amount of insulin needed to keep the wearer's blood sugar levels steady, which is delivered via a pump. (Source: the Mail online | Health)
Source: the Mail online | Health - April 1, 2024 Category: Consumer Health News Source Type: news
A link between ghrelin and major depressive disorder: a mini review - Lis M, Mi łuch T, Majdowski M, Zawodny T.
Ghrelin is primarily responsible for regulating energy balance, as it increases appetite. However, in recent years, its new physiological functions have been discovered-it regulates lipogenesis, plays a role in the development of insulin resistance, and ev... (Source: SafetyLit)
Source: SafetyLit - March 30, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Metabolic consequences of anabolic steroids, insulin, and growth hormone abuse in recreational bodybuilders: implications for the World Anti-Doping Agency Passport - Di Girolamo FG, Biasinutto C, Mangogna A, Fiotti N, Vinci P, Pi šot R, Mearelli F, Šimunič B, Roni C, Biolo G.
BACKGROUND: Hormonal doping in recreational sports is a public-health concern. The World Anti-Doping Agency (WADA) promoted the creation of the Athlete Biological Passport, aiming to monitor athlete's biological variables over time to facilitate indirect d... (Source: SafetyLit)
Source: SafetyLit - March 30, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Nurse charged in the deaths of 17 patients berated and bullied diabetic man before giving lethal insulin dose, suit says
The family of a severely diabetic man whom authorities said died at the hands of a nurse overseeing his care last year has filed a wrongful death suit against the facility where he lived, alleging it allowed the nurse to berate and bully him, and ultimately cause his death. Former nursing home…#heatherpressdee #pennsylvania #generalsoffice #butlercounty #nicholascymbol #robpeirce #pressdee #cymbol #sunnyview #melindabrown (Source: Reuters: Health)
Source: Reuters: Health - March 30, 2024 Category: Consumer Health News Source Type: news
Eli Lilly in advanced clinical trials for its weight-loss pill
Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess its safety and efficacy compared to insulin glargine in individuals with type-two diabetes and obesity or overweight at an increased cardiovascular risk. The company's spokesperson in India mentioned ongoing clinical studies on novel products, including orforglipron. (Source: The Economic Times)
Source: The Economic Times - March 28, 2024 Category: Consumer Health News Source Type: news
' From Interpretation to Action': Using CGM to Manage T2D'From Interpretation to Action': Using CGM to Manage T2D
Continuous glucose monitoring devices can help guide nutrition management and insulin dose adjustments in primary care.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 27, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It?
(MedPage Today) -- Both generic and branded formulations of 10-mL vials of insulin lispro injection (Humalog) will be temporarily out of stock through the start of April, Eli Lilly announced.
A new study predicted global fertility, which has been... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - March 26, 2024 Category: Endocrinology Source Type: news
Insulin Out-of-Pocket Cost Caps Do Not Increase Insulin Use
TUESDAY, March 26, 2024 -- Insulin out-of-pocket (OOP) cost caps are associated with a reduction in insulin OOP costs, but no increase in insulin use, according to a study published online March 26 in the Annals of Internal Medicine.
Laura F.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2024 Category: Pharmaceuticals Source Type: news
Eli Lilly Reports Temporary Shortage of Humalog and Insulin Lispro Injection
MONDAY, March 25, 2024 -- Eli Lilly& Co. announced on Friday a temporary shortage of two of its insulin products. " The 10 mL vials of Humalog and Insulin Lispro Injection are or will be temporarily out of stock at wholesalers and some... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 25, 2024 Category: Pharmaceuticals Source Type: news
Out-of-Pocket Insulin Caps Boost Savings -- But Not Insulin Use
(MedPage Today) -- While out-of-pocket caps on insulin indeed cut down on costs for commercially insured patients in the U.S., the policies didn't do much to increase insulin use, claims data showed.
After such policies were implemented in eight... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - March 25, 2024 Category: Urology & Nephrology Source Type: news
Drug manufacturer Eli Lilly says two of its diabetes drugs are in short supply - as millions of patients face weeks of chaos
Pharmaceutical giant Eli Lilly announced a temporary shortage of two types of insulin, a medicine taken by more than six million Americans. (Source: the Mail online | Health)
Source: the Mail online | Health - March 25, 2024 Category: Consumer Health News Source Type: news
